Position in LEGN
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$14,544,360
-$2,934,600 QoQ
Shares Held
804,000
0.0% QoQ
Ownership
0.217%
of shares outstanding
% of Portfolio
8.24%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 80.64676616915423.ToString("F0")%
Shared 0.ToString("F0")%
None 19.35323383084577.ToString("F0")%
Common Shares in LEGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026IvyRock Asset Management (HK) Ltd holds $15,957,002 across 6 Biotechnology names. LEGN ranks #1 (91.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LEGN |
Legend Biotech Corp
This page
|
804,000 | $14,544,360 | |
| 2 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
7,000 | $438,900 | |
| 3 | AVBP |
ArriVent BioPharma, Inc.
|
16,000 | $369,120 | |
| 4 | NTLA |
Intellia Therapeutics, Inc.
|
19,830 | $254,220 | |
| 5 | BEAM |
Beam Therapeutics Inc.
|
8,600 | $204,938 | |
| 6 | PRME |
Prime Medicine, Inc.
|
41,800 | $145,464 |
All Filings in LEGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,544,360 | 804,000 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $17,478,960 | 804,000 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $27,943,509 | 856,900 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $30,872,751 | 869,900 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $28,636,920 | 844,000 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $8,691,434 | 267,100 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $331,364 | 6,800 | Shares | Sole | 2024-11-08 | |
| No filing history on record for this holder in this stock. | ||||||